MichaelJamesMarmuraMD

PubMed

• Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
  Paul Rizzoli, Michael J Marmura, Jennifer Robblee, Jennifer McVige, Sara Sacco, Stephanie J Nahas, Jessica Ailani, Rosa De Abreu Ferreira, Julia Ma, Jonathan H Smith, ...> ;The Journal of Headache and Pain. 2024 Mar 11
• 1 citations
  Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis.
  Hsiangkuo Yuan, Aniket Natekar, Jade Park, Clinton G Lauritsen, Eugene R Viscusi, Michael J Marmura> ;Regional Anesthesia and Pain Medicine. 2023 Dec 1
• 5 citations
  Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.
  Amaal J Starling, Robert P Cowan, Dawn C Buse, Hans-Christoph Diener, Michael J Marmura, Joe Hirman, Thomas Brevig, Roger Cady> ;Headache. 2023 Feb 1
• 7 citations
  Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE ...
  Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan, Joel M Tr...> ;Cephalalgia. 2023 Jan 1
• 1 citations
  Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
  Robert P Cowan, Michael J Marmura, Hans-Christoph Diener, Amaal J Starling, Jack Schim, Joe Hirman, Thomas Brevig, Roger Cady> ;The Journal of Headache and Pain. 2022 Sep 6
• Hemicrania continua unresponsive to indomethacin do exist.
  Prakash S, Shah ND, Marmura MJ> ;Cephalalgia : an international journal of headache.
• Atogepant for the Preventive Treatment of Migraine.
  Ailani J, Lipton RB, Goadsby PJ, Guo H, Miceli R, Severt L, Finnegan M, Trugman JM, ADVANCE Study Group> ;The New England journal of medicine.
• 42 citations
  International consensus statement on allergy and rhinology: Olfaction.
  O'Brien, E. K., Zara M Patel, Eric H Holbrook, Justin H Turner, Nithin D Adappa, Mark W Albers, Aytug Altundag, Simone Appenzeller, Richard M Costanzo, Ilona Croy, Gre...> ;International Forum of Allergy & Rhinology. 2022 Apr 1
• 10 citations
  Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.
  Umer Najib, Timothy Smith, Nada Hindiyeh, Joel Saper, Barbara Nye, Sait Ashina, Candace K McClure, Michael J Marmura, Serena Chase, Eric Liebler, Lipton, R.> ;Cephalalgia. 2022 Jun 1
• 3 citations
  The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review.
  Christopher Gottschalk, Dawn C Buse, Michael J Marmura, Bradley Torphy, Jelena M Pavlovic, Paula K Dumas, Nim Lalvani, Andrew Blumenfeld> ;Therapeutic Advances in Neurological Disorders. 2022 Jan 1
• 19 citations
  Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migrain...
  Michael J. Marmura, Hans-Christoph Diener, Robert Cowan, Stewart J. Tepper, Merle L. Diamond, Amaal J. Starling, Joe Hirman, Lahar Mehta, Thomas Brevig, Roger Cady> ;Headache. 2021 Sep 22
• Updated process for American Headache Society Guidelines
  Andrew D. Hershey, Cynthia E. Armand, Thomas Berk, Dawn C. Buse, Carrie Dougherty, Michael J. Marmura, Mia T. Minen, Jennifer Robblee, Heidi B. Schwarz> ;Headache. 2021 Apr 1
• Comparing treatments in the emergency department: What works for migraine?
  Michael J. Marmura> ;Headache. 2021 Apr 1
• 9 citations
  Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.
  Stephen D. Silberstein, Joshua M. Cohen, Ronghua Yang, Sanjay K. Gandhi, Evelyn Du, Adelene E. Jann, Michael J. Marmura> ;The Journal of Headache and Pain. 2021 Jan 7
• 41 citations
  Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
  Hans-Christoph Diener, Michael J. Marmura, Stewart J. Tepper, Robert Cowan, Amaal J. Starling, Merle L. Diamond, Joe Hirman, Lahar Mehta, Thomas Brevig, Bjorn Sperling...> ;Headache. 2021 Jan 1
• 13 citations
  Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication Use: An Open-Label Extension Study
  Michael J. Marmura, Tamar Lin, Dagan Harris, Alon Ironi, Noah Rosen> ;Frontiers in Neurology. 2020 Apr 7
• 41 citations
  Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.
  Randolph W. Evans, Benjamin Frishberg, Michael J. Marmura, Laszlo L. Mechtler, Stephen D. Silberstein, Dana P. Turner> ;Headache. 2020 Feb 1
• 4 citations
  Inpatient Management of Migraine
  Michael J. Marmura, Angela Hou> ;Neurologic Clinics. 2019 Nov 1
• 93 citations
  Triggers, Protectors, and Predictors in Episodic Migraine.
  Michael J. Marmura> ;Current Pain and Headache Reports. 2018 Oct 5
• 6 citations
  Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders
  Michael J. Marmura, Aliza S Kumpinsky> ;CNS Drugs. 2018 Aug 1
• 82 citations
  A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study):
  Amaal J. Starling, Stewart J. Tepper, Michael J. Marmura, Ejaz A. Shamim, Matthew S. Robbins, Nada Hindiyeh, Andrew Charles, Peter J. Goadsby, Stephen D. Silberstein, ...> ;Cephalalgia. 2018 Mar 4
• 23 citations
  Current Treatment Options: Vestibular Migraine.
  Clinton G. Lauritsen, Michael J. Marmura> ;Current Treatment Options in Neurology. 2017 Sep 30
• 44 citations
  Ketamine Infusions for Treatment Refractory Headache.
  Jared L. Pomeroy, Michael J. Marmura, Stephanie J. Nahas, Eugene R. Viscusi> ;Headache. 2017 Feb 1
• Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.
  Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, Simmons KA, Mullin C, Liebler EJ, Goadsby PJ, Saper JR, EVENT Study Group> ;Neurology. 2016-07-13
• 19 citations
  How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine.
  Tamara Pringsheim, William Jeptha Davenport, Michael J. Marmura, Todd J. Schwedt, Stephen D. Silberstein> ;Headache. 2016 Jul 1
• Join now to see all